Enrollment complete in ORACLE MS study of cladribine tablets

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Enrollment complete in ORACLE MS study of cladribine tablets

Post by MSUK » Wed Nov 17, 2010 1:25 am

Image

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the completion of patient enrollment in the ORACLE MS1 clinical study. This randomized, double blind, placebo-controlled, international Phase III trial is designed to evaluate the therapeutic effects of Cladribine Tablets on the time to conversion to multiple sclerosis (MS) in people with a first clinical event suggestive of the disease.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post